124 related articles for article (PubMed ID: 26707830)
1. Association of TIMP3 expression with vessel density, macrophage infiltration and prognosis in human malignant melanoma.
Das AM; Koljenović S; Oude Ophuis CM; van der Klok T; Galjart B; Nigg AL; van Cappellen WA; Noordhoek Hegt V; Dinjens WN; Atmodimedjo PN; Vermeulen CE; Verhoef C; Eggermont AM; ten Hagen TL
Eur J Cancer; 2016 Jan; 53():135-43. PubMed ID: 26707830
[TBL] [Abstract][Full Text] [Related]
2. Tissue inhibitor of metalloproteinase-3 (TIMP3) expression decreases during melanoma progression and inhibits melanoma cell migration.
Das AM; Bolkestein M; van der Klok T; Oude Ophuis CM; Vermeulen CE; Rens JA; Dinjens WN; Atmodimedjo PN; Verhoef C; Koljenović S; Smits R; Ten Hagen TL; Eggermont AM
Eur J Cancer; 2016 Oct; 66():34-46. PubMed ID: 27522248
[TBL] [Abstract][Full Text] [Related]
3. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
De Schutter H; Geeraerts H; Verbeken E; Nuyts S
Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
[TBL] [Abstract][Full Text] [Related]
4. Promoter methylation and expression of TIMP3 gene in gastric cancer.
Guan Z; Zhang J; Song S; Dai D
Diagn Pathol; 2013 Jul; 8():110. PubMed ID: 23819566
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of MGMT gene promoter methylation in differently treated metastatic melanomas.
Cesinaro AM; Sartori G; Migaldi M; Schirosi L; Pellacani G; Collina G; Maiorana A
Pathology; 2012 Jun; 44(4):313-7. PubMed ID: 22544212
[TBL] [Abstract][Full Text] [Related]
6. Loss of expression of TIMP3 in clear cell renal cell carcinoma.
Masson D; Rioux-Leclercq N; Fergelot P; Jouan F; Mottier S; Théoleyre S; Bach-Ngohou K; Patard JJ; Denis MG
Eur J Cancer; 2010 May; 46(8):1430-7. PubMed ID: 20194016
[TBL] [Abstract][Full Text] [Related]
7. Differential TIMP3 expression affects tumor progression and angiogenesis in melanomas through regulation of directionally persistent endothelial cell migration.
Das AM; Seynhaeve AL; Rens JA; Vermeulen CE; Koning GA; Eggermont AM; Ten Hagen TL
Angiogenesis; 2014 Jan; 17(1):163-77. PubMed ID: 24221409
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.
Donizy P; Zietek M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
Diagn Pathol; 2015 Jul; 10():86. PubMed ID: 26134500
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation contributes to TIMP3 down-regulation in high stage endometrioid endometrial carcinomas.
Catasus L; Pons C; Muñoz J; Espinosa I; Prat J
Histopathology; 2013 Mar; 62(4):632-41. PubMed ID: 23379820
[TBL] [Abstract][Full Text] [Related]
10. Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma.
Storr SJ; Safuan S; Mitra A; Elliott F; Walker C; Vasko MJ; Ho B; Cook M; Mohammed RA; Patel PM; Ellis IO; Newton-Bishop JA; Martin SG
Mod Pathol; 2012 Apr; 25(4):493-504. PubMed ID: 22080065
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation and promoter methylation of tissue inhibitor of metalloproteinase 3 in choriocarcinoma.
Feng H; Cheung AN; Xue WC; Wang Y; Wang X; Fu S; Wang Q; Ngan HY; Tsao SW
Gynecol Oncol; 2004 Aug; 94(2):375-82. PubMed ID: 15297175
[TBL] [Abstract][Full Text] [Related]
12. TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis.
Huang HL; Liu YM; Sung TY; Huang TC; Cheng YW; Liou JP; Pan SL
Theranostics; 2019; 9(22):6676-6689. PubMed ID: 31588243
[TBL] [Abstract][Full Text] [Related]
13. Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma.
de Unamuno Bustos B; Murria Estal R; Pérez Simó G; Simarro Farinos J; Pujol Marco C; Navarro Mira M; Alegre de Miquel V; Ballester Sánchez R; Sabater Marco V; Llavador Ros M; Palanca Suela S; Botella Estrada R
Br J Dermatol; 2018 Aug; 179(2):394-404. PubMed ID: 29278418
[TBL] [Abstract][Full Text] [Related]
14. Paucity of tumor-infiltrating lymphocytes is an unfavorable prognosticator and predicts lymph node metastases in cutaneous melanoma patients.
Donizy P; Kaczorowski M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
Anticancer Res; 2015 Jan; 35(1):351-8. PubMed ID: 25550571
[TBL] [Abstract][Full Text] [Related]
15. TIMP3 regulates migration, invasion and in vivo tumorigenicity of thyroid tumor cells.
Anania MC; Sensi M; Radaelli E; Miranda C; Vizioli MG; Pagliardini S; Favini E; Cleris L; Supino R; Formelli F; Borrello MG; Pierotti MA; Greco A
Oncogene; 2011 Jul; 30(27):3011-23. PubMed ID: 21339735
[TBL] [Abstract][Full Text] [Related]
16. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
[TBL] [Abstract][Full Text] [Related]
17. Novel role for RGS1 in melanoma progression.
Rangel J; Nosrati M; Leong SP; Haqq C; Miller JR; Sagebiel RW; Kashani-Sabet M
Am J Surg Pathol; 2008 Aug; 32(8):1207-12. PubMed ID: 18580492
[TBL] [Abstract][Full Text] [Related]
18. E- to N-cadherin switch in melanoma is associated with decreased expression of phosphatase and tensin homolog and cancer progression.
Lade-Keller J; Riber-Hansen R; Guldberg P; Schmidt H; Hamilton-Dutoit SJ; Steiniche T
Br J Dermatol; 2013 Sep; 169(3):618-28. PubMed ID: 23662813
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological implications of tumour-associated macrophages and vascularization in sinonasal melanoma.
Shi L; Lei D; Ma C; Xu F; Li Y; Wang Y; Cong N; Liu D; Pan XL
J Int Med Res; 2010; 38(4):1276-86. PubMed ID: 20926000
[TBL] [Abstract][Full Text] [Related]
20. Alterations of the tissue inhibitor of metalloproteinase-3 (TIMP3) gene in pancreatic adenocarcinomas.
Fendrich V; Slater EP; Heinmöller E; Ramaswamy A; Celik I; Nowak O; Chaloupka B; Gerdes B; Bartsch DK
Pancreas; 2005 Mar; 30(2):e40-5. PubMed ID: 15714128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
